ICLR vs. LH: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ICLR and LH, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | ICLR | LH |
|---|---|---|
| Company Name | ICON Public Limited Company | Labcorp Holdings Inc. |
| Country | Ireland | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Life Sciences Tools & Services | Health Care Providers & Services |
| Market Capitalization | 12.41 billion USD | 22.18 billion USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | May 15, 1998 | March 29, 1990 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of ICLR and LH by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | ICLR | LH |
|---|---|---|
| 5-Day Price Return | 2.85% | 2.21% |
| 13-Week Price Return | -7.77% | -1.29% |
| 26-Week Price Return | 15.44% | 6.75% |
| 52-Week Price Return | -20.46% | 8.39% |
| Month-to-Date Return | -5.61% | 5.09% |
| Year-to-Date Return | -22.66% | 16.38% |
| 10-Day Avg. Volume | 0.64M | 1.27M |
| 3-Month Avg. Volume | 1.15M | 0.72M |
| 3-Month Volatility | 42.52% | 24.68% |
| Beta | 1.28 | 0.98 |
Profitability
Return on Equity (TTM)
ICLR
6.32%
Life Sciences Tools & Services Industry
- Max
- 23.81%
- Q3
- 11.79%
- Median
- 7.51%
- Q1
- 3.14%
- Min
- -6.95%
ICLR’s Return on Equity of 6.32% is on par with the norm for the Life Sciences Tools & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.
LH
10.20%
Health Care Providers & Services Industry
- Max
- 24.67%
- Q3
- 15.54%
- Median
- 8.37%
- Q1
- 5.49%
- Min
- -2.09%
LH’s Return on Equity of 10.20% is on par with the norm for the Health Care Providers & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
ICLR
7.40%
Life Sciences Tools & Services Industry
- Max
- 33.77%
- Q3
- 17.97%
- Median
- 8.97%
- Q1
- 3.80%
- Min
- -11.89%
ICLR’s Net Profit Margin of 7.40% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
LH
6.21%
Health Care Providers & Services Industry
- Max
- 9.33%
- Q3
- 4.80%
- Median
- 2.90%
- Q1
- 0.93%
- Min
- -3.28%
A Net Profit Margin of 6.21% places LH in the upper quartile for the Health Care Providers & Services industry, signifying strong profitability and more effective cost management than most of its peers.
Operating Profit Margin (TTM)
ICLR
10.03%
Life Sciences Tools & Services Industry
- Max
- 31.55%
- Q3
- 21.26%
- Median
- 14.06%
- Q1
- 8.54%
- Min
- 0.11%
ICLR’s Operating Profit Margin of 10.03% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
LH
9.69%
Health Care Providers & Services Industry
- Max
- 18.35%
- Q3
- 8.71%
- Median
- 5.10%
- Q1
- 2.10%
- Min
- -3.07%
An Operating Profit Margin of 9.69% places LH in the upper quartile for the Health Care Providers & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
| Symbol | ICLR | LH |
|---|---|---|
| Return on Equity (TTM) | 6.32% | 10.20% |
| Return on Assets (TTM) | 3.59% | 4.73% |
| Net Profit Margin (TTM) | 7.40% | 6.21% |
| Operating Profit Margin (TTM) | 10.03% | 9.69% |
| Gross Profit Margin (TTM) | 28.15% | 28.45% |
Financial Strength
Current Ratio (MRQ)
ICLR
1.06
Life Sciences Tools & Services Industry
- Max
- 4.76
- Q3
- 2.87
- Median
- 1.75
- Q1
- 1.37
- Min
- 0.57
ICLR’s Current Ratio of 1.06 falls into the lower quartile for the Life Sciences Tools & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
LH
1.55
Health Care Providers & Services Industry
- Max
- 2.00
- Q3
- 1.56
- Median
- 1.28
- Q1
- 0.92
- Min
- 0.01
LH’s Current Ratio of 1.55 aligns with the median group of the Health Care Providers & Services industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
ICLR
0.37
Life Sciences Tools & Services Industry
- Max
- 0.95
- Q3
- 0.70
- Median
- 0.45
- Q1
- 0.18
- Min
- 0.00
ICLR’s Debt-to-Equity Ratio of 0.37 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
LH
0.65
Health Care Providers & Services Industry
- Max
- 2.41
- Q3
- 1.39
- Median
- 0.74
- Q1
- 0.46
- Min
- 0.00
LH’s Debt-to-Equity Ratio of 0.65 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
ICLR
4.80
Life Sciences Tools & Services Industry
- Max
- 45.00
- Q3
- 27.84
- Median
- 7.16
- Q1
- 2.12
- Min
- -14.08
ICLR’s Interest Coverage Ratio of 4.80 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.
LH
5.73
Health Care Providers & Services Industry
- Max
- 14.47
- Q3
- 7.46
- Median
- 4.52
- Q1
- 2.04
- Min
- -4.44
LH’s Interest Coverage Ratio of 5.73 is positioned comfortably within the norm for the Health Care Providers & Services industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | ICLR | LH |
|---|---|---|
| Current Ratio (MRQ) | 1.06 | 1.55 |
| Quick Ratio (MRQ) | 1.02 | 1.09 |
| Debt-to-Equity Ratio (MRQ) | 0.37 | 0.65 |
| Interest Coverage Ratio (TTM) | 4.80 | 5.73 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
ICLR
0.00%
Life Sciences Tools & Services Industry
- Max
- 1.02%
- Q3
- 0.67%
- Median
- 0.32%
- Q1
- 0.00%
- Min
- 0.00%
ICLR currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
LH
1.11%
Health Care Providers & Services Industry
- Max
- 5.51%
- Q3
- 2.66%
- Median
- 1.06%
- Q1
- 0.00%
- Min
- 0.00%
LH’s Dividend Yield of 1.11% is consistent with its peers in the Health Care Providers & Services industry, providing a dividend return that is standard for its sector.
Dividend Payout Ratio (TTM)
ICLR
0.00%
Life Sciences Tools & Services Industry
- Max
- 97.67%
- Q3
- 61.34%
- Median
- 18.53%
- Q1
- 0.00%
- Min
- 0.00%
ICLR has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
LH
28.24%
Health Care Providers & Services Industry
- Max
- 187.56%
- Q3
- 81.14%
- Median
- 33.42%
- Q1
- 0.00%
- Min
- 0.00%
LH’s Dividend Payout Ratio of 28.24% is within the typical range for the Health Care Providers & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | ICLR | LH |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 1.11% |
| Dividend Payout Ratio (TTM) | 0.00% | 28.24% |
Valuation
Price-to-Earnings Ratio (TTM)
ICLR
20.85
Life Sciences Tools & Services Industry
- Max
- 78.22
- Q3
- 57.42
- Median
- 34.18
- Q1
- 28.39
- Min
- 1.55
In the lower quartile for the Life Sciences Tools & Services industry, ICLR’s P/E Ratio of 20.85 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
LH
25.34
Health Care Providers & Services Industry
- Max
- 48.86
- Q3
- 32.22
- Median
- 21.78
- Q1
- 13.97
- Min
- 8.01
LH’s P/E Ratio of 25.34 is within the middle range for the Health Care Providers & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
ICLR
1.54
Life Sciences Tools & Services Industry
- Max
- 10.69
- Q3
- 6.37
- Median
- 4.95
- Q1
- 3.27
- Min
- 1.04
In the lower quartile for the Life Sciences Tools & Services industry, ICLR’s P/S Ratio of 1.54 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.
LH
1.57
Health Care Providers & Services Industry
- Max
- 3.66
- Q3
- 1.64
- Median
- 0.72
- Q1
- 0.27
- Min
- 0.10
LH’s P/S Ratio of 1.57 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
ICLR
1.46
Life Sciences Tools & Services Industry
- Max
- 8.12
- Q3
- 5.04
- Median
- 3.94
- Q1
- 2.12
- Min
- 1.13
ICLR’s P/B Ratio of 1.46 is in the lower quartile for the Life Sciences Tools & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
LH
2.74
Health Care Providers & Services Industry
- Max
- 7.33
- Q3
- 4.33
- Median
- 2.48
- Q1
- 1.31
- Min
- 0.65
LH’s P/B Ratio of 2.74 is within the conventional range for the Health Care Providers & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | ICLR | LH |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 20.85 | 25.34 |
| Price-to-Sales Ratio (TTM) | 1.54 | 1.57 |
| Price-to-Book Ratio (MRQ) | 1.46 | 2.74 |
| Price-to-Free Cash Flow Ratio (TTM) | 12.96 | 14.56 |